February 24, 2025 · STOCK Act disclosure
Representative Jefferson Shreve (Republican-IN) bought Amgen Inc., a stock transaction, valued at $15,001 - $50,000. The trade took place on February 24, 2025 and was disclosed on March 9, 2025 (owner: DC). Members of Congress must report such transactions within 45 days under the STOCK Act.